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Human metapneumovirus (hMPV), first described in 2001 [1], is responsible for causing serious 
respiratory  illness  in  young  children,  the  elderly  and  immunocompromised  patients.  Four  distinct 
lineages of hMPV have been identified with the original nomenclature for these subgroups (A1, A2, 
B1 and B2), reported by van den Hoogen et al. [2], utilised by many. An alternate terminology (1A, 
1B, 2A and 2B) was also published by Ishiguro et al. in 2004 [3] which has been adopted by others. 
However, this has caused some confusion in the interpretation of publication results as the terminology 
is  similar  yet  describes  different  subtypes.  As  a  result,  a  number  of  investigators  have  made  a 
submission to the International Committee on Taxonomy of Viruses (ICTV, ICTV taxonomic proposal 
2012.012V) for the official  adoption of the original terminology as an approved nomenclature for 
hMPV [4]. We welcome this officially approved nomenclature which should provide clarification of 
these subtypes in future. Therefore to assist with the interpretation of our recently published research 
in the 2012 special issue of Viruses: Pneumoviruses and Metapneumoviruses entitled “Diversity in 
Glycosaminoglycan Binding Amongst hMPV G Protein Lineages” [5] we have updated the Figure 3 in 
this  letter  (see  Figure  1),  showing  the  proposed  ICTV  terminology  compared  to  the  Ishiguro 
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classification (used in our publication). Note that in the original publication the alphanumeric order for 
the Ishiguro classification was transposed (e.g., 1A was referred to as A1). 
Figure 1. Comparison of the predicted amino acid sequence for representatives of each 
strain  of  human  metapneumovirus  (hMPV)  G  protein  (residues  98–136/137/142  of  the 
extracellular domain). Strains ordered by Ishiguro’s classification are shown in blue and 
strains ordered by the proposed International Committee on Taxonomy of Viruses (ICTV) 
nomenclature are shown in green.  The number of positively charged residues (shown in 
red  in  the  sequence)  is  indicated  in  brown  at  the  end  of  each  sequence.  The  yellow 
highlights  in  the  2B/B1  sequence  indicate  the  previously  identified  heparin  binding 
domains [6]. 
Ishiguro                  ICTV 
  1A   98 TKNNPRTSSR------TRSPPRATTRSVRRTTTLHTSSIRKRPPT 136 11   A1 
  2A   98 EKKPTGATTK-----KEKETTTRTTSTAATQTLNTTNQTSNGREA 137 7   B2 
  1B   98 IRNNLSTASS------TQSSPRAATKAIRRATTFRMSSTGRRPTT 136 8   A2 
  2B   98 EKKKTRATTQRRGKGKENTNQTTSTAATQTTNTTNQIRNASETIT 142 9   B1 
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